Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Galera Therapeutics Inc | GRTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.2075 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.2075 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.0853 - 3.59 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.2075 | USD |
Galera Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 11.42M | 54.39M | - | 0 | -59.08M | -1.09 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Galera Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GRTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.1875 | 0.21 | 0.162 | 0.1909131 | 664,029 | 0.02 | 10.67% |
| 1 Month | 0.19395 | 0.2385 | 0.1475 | 0.1784365 | 2,967,244 | 0.01355 | 6.99% |
| 3 Months | 0.18 | 0.29 | 0.1314 | 0.2014235 | 2,071,236 | 0.0275 | 15.28% |
| 6 Months | 0.197 | 0.29 | 0.0853 | 0.1746643 | 2,551,884 | 0.0105 | 5.33% |
| 1 Year | 2.76 | 3.59 | 0.0853 | 0.4840424 | 2,655,736 | -2.55 | -92.48% |
| 3 Years | 6.56 | 10.79 | 0.0853 | 2.03 | 2,110,142 | -6.35 | -96.84% |
| 5 Years | 12.50 | 19.50 | 0.0853 | 2.16 | 1,431,463 | -12.29 | -98.34% |
Galera Therapeutics Description
| Galera Therapeutics Inc is a biopharmaceutical company focused on developing therapeutics that have the potential to transform radiotherapy in cancer. |
